Abstract
Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 45-46 |
| Numero di pagine | 2 |
| Rivista | Clinical Neuropharmacology |
| Volume | 35 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Gabapentin
- Somatoform Disorders